Monday, August 15, 2011
Part 3: The Ellis Martin Report with Ken Aldrich of Int Stem Cell Corp (ISCO.OB)
Ellis Martin of The Ellis Martin Report interviews Ken Aldrich of International Stem Cell Corporation (ISCO.OB) on the latest research involving stem cell technology utilizing unfertilized eggs, as a basis for cell generation with a goal toward organ transplants which are immune to rejection by the body...as well as other applications. Mr. Aldrich also discusses neurological applications focusing on reversing Parkinson's disease. Preventing and reversing blindness is another topic covered.
contact:martinrepots@gmail.com
International Stem cell Corporation is a paid sponsor of The Ellis Martin Report
Posted by PSEO at 9:03 AM
Labels: biotechnology, International Stem Cell Corporation, liver disease, parkinsons disease, pluripotent, regenerative medicine, stem cell research, stem cell stock